| Literature DB >> 2959699 |
P J Cowen1, E M Charig, S Fraser, J M Elliott.
Abstract
5-Hydroxytryptamine (5-HT) receptor binding was determined in intact human platelets using 125I-iodolysergic acid diethylamide (125I-iodoLSD). The assay revealed that platelets possess a single population of specific binding sites for 125I-iodoLSD which have a high affinity for the 5-HT2 receptor antagonists, ketanserin and spiperone. There was no difference in platelet 125I-iodoLSD receptor binding between depressed patients and controls. However, treatment with tricyclic antidepressants increased the number of 125I-iodoLSD receptor binding sites without significantly altering their affinity.Entities:
Mesh：
Substances：
Year: 1987 PMID： 2959699 DOI： 10.1016/0165-0327(87)90072-3
Source DB: PubMed Journal: J Affect Disord ISSN： 0165-0327 Impact factor: 4.839